HemaSphere (Aug 2023)
PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY
- Ziyu LI,
- Qian Jiang,
- Xiaoshuai Zhang,
- Yanli Zhang,
- Na Xu,
- Huanling Zhu,
- Hai Lin,
- Weiming LI,
- Xin Du,
- Rong Liang,
- Fei LI,
- Chunyan Chen,
- Bingcheng Liu,
- Xiaodong Wang,
- Lijie Yang,
- Zhenfang Liu,
- Liping Pang,
- Zhuogang Liu,
- Xiuli Sun,
- Yanliang Bai,
- LI Meng,
- Suning Chen
Affiliations
- Ziyu LI
- 1 Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, China
- Qian Jiang
- 1 Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, China
- Xiaoshuai Zhang
- 1 Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, China
- Yanli Zhang
- 2 , China
- Na Xu
- 2 , China
- Huanling Zhu
- 2 , China
- Hai Lin
- 2 , China
- Weiming LI
- 2 , China
- Xin Du
- 2 , China
- Rong Liang
- 2 , China
- Fei LI
- 2 , China
- Chunyan Chen
- 2 , China
- Bingcheng Liu
- 2 , China
- Xiaodong Wang
- 2 , China
- Lijie Yang
- 2 , China
- Zhenfang Liu
- 2 , China
- Liping Pang
- 2 , China
- Zhuogang Liu
- 2 , China
- Xiuli Sun
- 2 , China
- Yanliang Bai
- 2 , China
- LI Meng
- 2 , China
- Suning Chen
- 2 , China
- DOI
- https://doi.org/10.1097/01.HS9.0000974688.76077.3c
- Journal volume & issue
-
Vol. 7
p. e760773c
Abstract
No abstracts available.